Page last updated: 2024-08-23

selegiline and Apoplexy

selegiline has been researched along with Apoplexy in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Amiri, S; Baghdadchi, Y; Gharbavi, M; Hosseini, MJ; Jafari, B; Jafari-Anarkoli, I; Mahmoudi, J; Manjili, HK1
Han, W; Li, H; Yang, H1
Bartolo, M; Capone, A; Pierelli, F; Sandrini, G; Zucchella, C1
Aaltonen, H; Heinonen, E; Kilkku, O; Reinikainen, K; Sarasoja, T; Sivenius, J1

Trials

2 trial(s) available for selegiline and Apoplexy

ArticleYear
An explorative study regarding the effect of l-deprenyl on cognitive and functional recovery in patients after stroke.
    Journal of the neurological sciences, 2015, Feb-15, Volume: 349, Issue:1-2

    Topics: Aged; Attention; Case-Control Studies; Cognition; Executive Function; Female; Humans; Male; Middle Aged; Monoamine Oxidase Inhibitors; Neuropsychological Tests; Recovery of Function; Selegiline; Stroke

2015
Selegiline treatment facilitates recovery after stroke.
    Neurorehabilitation and neural repair, 2001, Volume: 15, Issue:3

    Topics: Acute Disease; Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuroprotective Agents; Recovery of Function; Selegiline; Stroke; Stroke Rehabilitation; Treatment Outcome

2001

Other Studies

2 other study(ies) available for selegiline and Apoplexy

ArticleYear
Mitigated Oxidative Stress and Cognitive Impairments in Transient Global Ischemia using Niosomal Selegiline-NBP delivery.
    Behavioural neurology, 2022, Volume: 2022

    Topics: Animals; Cognitive Dysfunction; Hypoxia; Ischemia; Neuroprotective Agents; Oxidative Stress; Rats; Selegiline; Stroke

2022
Efficacy and safety of MAO-B inhibitor versus donepezil in Chinese elderly stroke patients with Alzheimer disease: A potential therapeutic option.
    Pakistan journal of pharmaceutical sciences, 2020, Volume: 33, Issue:3(Special)

    Topics: Age Factors; Aged; Alzheimer Disease; China; Cholinesterase Inhibitors; Cognition; Donepezil; Female; Humans; Male; Monoamine Oxidase Inhibitors; Nootropic Agents; Pilot Projects; Random Allocation; Selegiline; Stroke; Time Factors; Treatment Outcome

2020